###begin article-title 0
###xml 0 5 0 5 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mclk1</italic>
###xml 5 9 5 9 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/- </sup>
###xml 9 13 <span type="species:ncbi:10090">mice</span>
Mclk1+/- mice are not resistant to the development of atherosclerosis
###end article-title 0
###begin p 1
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
###end p 1
###begin title 2
Background
###end title 2
###begin p 3
###xml 27 33 27 33 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mclk1 </italic>
###xml 41 45 41 45 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Coq7</italic>
###xml 407 411 407 411 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ApoE</italic>
###xml 411 414 411 414 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 472 476 472 476 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LDLr</italic>
###xml 476 479 476 479 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 566 572 566 572 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mclk1 </italic>
###xml 0 4 <span type="species:ncbi:10090">Mice</span>
###xml 183 187 <span type="species:ncbi:10090">mice</span>
###xml 345 351 <span type="species:ncbi:9606">humans</span>
###xml 374 378 <span type="species:ncbi:10090">mice</span>
###xml 419 423 <span type="species:ncbi:10090">mice</span>
Mice with a single copy of Mclk1 (a.k.a. Coq7), a gene that encodes a mitochondrial enzyme required for the biosynthesis of ubiquinone and other functions, live longer than wild-type mice. The prolonged survival implies a decreased mortality from age-dependent lethal pathologies. Atherosclerosis is one of the main age-dependent pathologies in humans and can be modeled in mice that lack Apolipoprotein E (ApoE-/-) or mice that lack the Low Density Lipoprotein Receptor (LDLr-/-) in addition to being fed an atherosclerosis-inducing diet. We sought to determine if Mclk1 heterozygosity protects against atherosclerosis and dyslipidemia in these models.
###end p 3
###begin title 4
Results
###end title 4
###begin p 5
###xml 14 20 14 20 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mclk1 </italic>
###xml 191 196 191 196 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ApoE </italic>
###xml 241 247 241 247 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mclk1 </italic>
###xml 157 161 <span type="species:ncbi:10090">mice</span>
We found that Mclk1 heterozygosity did not protect against dyslipidemia, oxidative stress, or atherosclerosis in young (6 or 10 months) or older (18 months) mice. Furthermore, the absence of ApoE suppressed the lifespan-promoting effects of Mclk1 heterozygosity.
###end p 5
###begin title 6
Conclusion
###end title 6
###begin p 7
###xml 38 44 38 44 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mclk1 </italic>
###xml 215 221 215 221 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mclk1 </italic>
###xml 82 86 <span type="species:ncbi:10090">mice</span>
These findings indicate that although Mclk1 heterozygosity can extend lifespan of mice, it does not necessarily protect against atherosclerosis. Moreover, in the presence of hyperlipidemia and chronic inflammation, Mclk1 heterozygosity is incapable of extending lifespan.
###end p 7
###begin title 8
Introduction
###end title 8
###begin p 9
###xml 54 59 54 59 <italic xmlns:xlink="http://www.w3.org/1999/xlink">clk-1</italic>
###xml 118 124 118 124 <italic xmlns:xlink="http://www.w3.org/1999/xlink">clk-1 </italic>
###xml 134 139 134 139 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mclk1</italic>
###xml 144 167 144 167 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Caenorhabditis elegans </italic>
###xml 191 192 191 192 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
###xml 193 194 193 194 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B3">3</xref>
###xml 304 305 304 305 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B4">4</xref>
###xml 306 307 306 307 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B5">5</xref>
###xml 521 522 521 522 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B6">6</xref>
###xml 525 530 525 530 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mclk1</italic>
###xml 537 542 537 542 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mclk1</italic>
###xml 542 545 542 545 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 614 620 614 620 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mclk1 </italic>
###xml 634 639 634 639 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mclk1</italic>
###xml 639 642 639 642 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/-</sup>
###xml 714 715 714 715 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 716 717 716 717 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B8">8</xref>
###xml 769 775 769 775 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mclk1 </italic>
###xml 818 819 818 819 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B3">3</xref>
###xml 820 821 820 821 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B9">9</xref>
###xml 144 166 <span type="species:ncbi:6239">Caenorhabditis elegans</span>
###xml 171 175 <span type="species:ncbi:10090">mice</span>
###xml 654 658 <span type="species:ncbi:10090">mice</span>
###xml 849 854 <span type="species:ncbi:10090">mouse</span>
Median lifespan is increased by mutations in the gene clk-1, and by heterozygosity for a null allele of the mammalian clk-1 homologue Mclk1, in Caenorhabditis elegans and mice, respectively [1-3]. CLK-1/MCLK1 is a mitochondrial hydroxylase required for the biosynthesis of ubiquinone (UQ or Coenzyme Q) [4,5], a lipid-like molecule that plays a vital role as an electron transporter in the mitochondrial electron transport chain, is an important lipid-soluble antioxidant, and also performs a variety of other functions [6]. Mclk1-null (Mclk1-/-) cells and embryos make no UQ and the embryos are not viable, while Mclk1 heterozygous (Mclk1+/-) cells and mice are superficially normal and show normal levels of UQ [7,8]. While the biochemical phenotypes associated with Mclk1 heterozygosity have begun to be uncovered [3,9], the actual effect on the mouse in terms of resistance to the physical decline associated with age and to age-dependent disease has not yet been examined.
###end p 9
###begin p 10
###xml 245 247 245 247 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B10">10</xref>
###xml 248 250 248 250 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B11">11</xref>
###xml 357 362 357 362 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mclk1</italic>
###xml 362 366 362 366 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/- </sup>
###xml 819 821 819 821 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
###xml 1020 1027 1020 1027 <sup xmlns:xlink="http://www.w3.org/1999/xlink">shc-/- </sup>
###xml 1186 1188 1186 1188 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
###xml 1189 1191 1189 1191 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 1207 1212 1207 1212 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mclk1</italic>
###xml 1212 1216 1212 1216 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/- </sup>
###xml 18 24 <span type="species:ncbi:9606">humans</span>
###xml 396 400 <span type="species:ncbi:10090">mice</span>
###xml 877 881 <span type="species:ncbi:10090">mice</span>
###xml 951 955 <span type="species:ncbi:10090">mice</span>
###xml 980 984 <span type="species:ncbi:10090">mice</span>
###xml 1036 1051 <span type="species:ncbi:10090">transgenic mice</span>
###xml 1216 1220 <span type="species:ncbi:10090">mice</span>
The longest-lived humans display an increased resistance to the common age-dependent diseases (cardiovascular disease, stroke, cancer, etc.), as the majority of them either develop these diseases later than the general population or not at all [10,11]. It is therefore tempting to expect a similar resistance to the development of age-dependent diseases in Mclk1+/- and other lines of long-lived mice. One particularly prevalent age-dependent disease is atherosclerosis, in which the oxidative modification of low-density lipoprotein and the resultant recognition by cells of the immune system results in a chronic inflammatory state within the wall of blood vessels. This leads to the formation of a plaque containing a mixture of extracellular cholesterol deposits, immune cells and infiltrating smooth muscle cells [12]. Interestingly, manipulations that extend lifespan in mice have been shown to protect against atherosclerosis. Among long-lived mice, calorically restricted mice as well as genetically modified p66shc-/- and UCP1 transgenic mice have been evaluated for atherosclerosis susceptibility. The fact that both were found to have an increased resistance to the disease [13-15] suggests that Mclk1+/- mice may also be resistant to the disease.
###end p 10
###begin p 11
###xml 47 53 47 53 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mclk1 </italic>
###xml 107 113 107 113 <italic xmlns:xlink="http://www.w3.org/1999/xlink">clk-1 </italic>
###xml 218 220 218 220 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
###xml 454 456 454 456 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
###xml 457 459 457 459 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B18">18</xref>
###xml 664 666 664 666 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
A further incentive for studying the effect of Mclk1 heterozygosity on atherosclerosis is the finding that clk-1 worms have an altered lipid metabolism, consistent with a decrease in oxidatively modified lipoproteins [16]. Furthermore, the core non-lipid component of these particles appears to be vitellogenin, a protein that is homologous to apolipoprotein B, the main structural component of atherosclerosis-inducing lipoprotein particles in mammals [17,18]. The conservation of lipid metabolism between worms and mammals was further confirmed by the finding that several lipid-lowering drugs developed in mammals are active on lipoprotein metabolism in worms [19].
###end p 11
###begin p 12
###xml 236 242 236 242 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mclk1 </italic>
###xml 543 545 543 545 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B20">20</xref>
###xml 546 548 546 548 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B21">21</xref>
###xml 654 658 654 658 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LDLr</italic>
###xml 658 661 658 661 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 730 734 730 734 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ApoE</italic>
###xml 734 737 734 737 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 857 859 857 859 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B22">22</xref>
###xml 860 862 860 862 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B23">23</xref>
###xml 1123 1125 1123 1125 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B24">24</xref>
###xml 1482 1484 1482 1484 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B25">25</xref>
###xml 46 50 <span type="species:ncbi:10090">mice</span>
###xml 537 541 <span type="species:ncbi:10090">mice</span>
###xml 551 555 <span type="species:ncbi:10090">Mice</span>
###xml 675 679 <span type="species:ncbi:10090">mice</span>
###xml 851 855 <span type="species:ncbi:10090">mice</span>
###xml 901 905 <span type="species:ncbi:10090">mice</span>
###xml 954 960 <span type="species:ncbi:9606">humans</span>
###xml 1051 1057 <span type="species:ncbi:9606">humans</span>
###xml 1438 1442 <span type="species:ncbi:10090">mice</span>
Atherosclerosis does not appear to develop in mice fed a regular diet, due to the partitioning of most cholesterol into the anti-atherogenic High Density Lipoprotein fraction of lipoproteins. Therefore, the lifespan extending effect of Mclk1 heterozygosity cannot be due to a decrease in atherosclerosis-related mortality. However, the underlying conditions thought to be responsible for atherosclerosis, oxidative stress and inflammation, are known to be strongly associated with aging, justifying the study of atherosclerosis in aging mice [20,21]. Mice lacking the Low Density Lipoprotein Receptor and fed a high-fat, high-cholesterol "Western" diet (LDLr-/-), as well as mice lacking apolipoprotein E fed a regular chow diet (ApoE-/-), develop hyperlipidemia and extensive aortic atherosclerosis, and are commonly used to model atherosclerosis in mice [22,23]. Although the lipid profile of these mice is characteristic of only the more dyslipidemic humans, the histopathological characteristics of the lesions appear similar to those observed in humans and other models, even if they develop over a shorter timeframe [24]. Furthermore, although coronary artery disease predominately affects those of middle-age or older, the atherosclerotic lesions that underlie the disease (and which are the focus of this study) begin to develop much earlier in life, with young adults having comparable aortic atherosclerosis to that observed in mice at an equivalent stage in their lives [25].
###end p 12
###begin p 13
###xml 206 208 206 208 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B26">26</xref>
###xml 209 211 209 211 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B28">28</xref>
###xml 231 235 231 235 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LDLr</italic>
###xml 235 239 235 239 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 291 295 291 295 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ApoE</italic>
###xml 295 299 295 299 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 343 349 343 349 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mclk1 </italic>
###xml 546 552 546 552 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mclk1 </italic>
###xml 613 619 613 619 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mclk1 </italic>
###xml 726 732 726 732 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mclk1 </italic>
###xml 803 807 803 807 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ApoE</italic>
###xml 807 811 807 811 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 453 457 <span type="species:ncbi:10090">mice</span>
###xml 811 815 <span type="species:ncbi:10090">mice</span>
We elected to use two separate models because, although they theoretically affect the same system (the uptake of lipid from the circulation), they are known to respond differently to certain interventions [26-28]. Importantly, the LDLr-/- model develops more severe atherosclerosis than the ApoE-/- model, allowing us to measure the effect of Mclk1 heterozygosity on atherosclerosis of both medium and high severity. We also measured atherosclerosis in mice of different ages, in order to detect any possible impact of an age-dependent effect of Mclk1 heterozygosity on atherosclerosis. Here, we demonstrate that Mclk1 heterozygosity does not consistently affect atherosclerosis or lipid profile in either model. Furthermore, Mclk1 heterozygosity fails to extend lifespan in atherosclerosis-susceptible ApoE-/- mice.
###end p 13
###begin title 14
Methods
###end title 14
###begin title 15
Animals and Diet
###end title 15
###begin p 16
###xml 0 4 0 4 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LDLr</italic>
###xml 4 8 4 8 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 9 11 9 11 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B29">29</xref>
###xml 17 21 17 21 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ApoE</italic>
###xml 21 25 21 25 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-\- </sup>
###xml 26 28 26 28 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B30">30</xref>
###xml 140 145 140 145 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mclk1</italic>
###xml 145 149 145 149 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/- </sup>
###xml 194 195 194 195 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 209 213 209 213 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LDLr</italic>
###xml 213 216 213 216 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 217 222 217 222 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mclk1</italic>
###xml 222 225 222 225 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+</sup>
###xml 227 231 227 231 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LDLr</italic>
###xml 231 234 231 234 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 235 240 235 240 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mclk1</italic>
###xml 240 243 240 243 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/-</sup>
###xml 245 249 245 249 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ApoE</italic>
###xml 249 252 249 252 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-\-</sup>
###xml 254 259 254 259 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mclk1</italic>
###xml 259 263 259 263 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+\+ </sup>
###xml 267 271 267 271 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ApoE</italic>
###xml 271 274 271 274 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-\-</sup>
###xml 276 281 276 281 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mclk1</italic>
###xml 281 285 281 285 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+\- </sup>
###xml 431 435 431 435 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LDLr</italic>
###xml 435 439 435 439 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 597 601 597 601 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ApoE</italic>
###xml 601 605 601 605 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 30 34 <span type="species:ncbi:10090">mice</span>
###xml 149 153 <span type="species:ncbi:10090">mice</span>
###xml 328 332 <span type="species:ncbi:10090">Mice</span>
###xml 419 423 <span type="species:ncbi:10090">mice</span>
###xml 585 589 <span type="species:ncbi:10090">Mice</span>
###xml 669 673 <span type="species:ncbi:10090">Mice</span>
LDLr-/- [29] and ApoE-\- [30] mice on a C57Bl/6J background were purchased from The Jackson Laboratory (Bar Harbor, ME) and were crossed to Mclk1+/- mice, previously produced by gene targeting [7], to produce LDLr-/-;Mclk1+/+, LDLr-/-;Mclk1+/-, ApoE-\-; Mclk1+\+ and ApoE-\-; Mclk1+\- animals. Genotypes were determined by PCR. Mice were maintained on 4.5% fat rodent chow (Charles River diet 5075). At 3 months of age mice in the LDLr-/- groups were placed on a "Western"-type diet (Harlan Teklad, Madison, WI, TD.01444) containing 21% (w/w) anhydrous milk fat and 0.15% cholesterol. Mice in the ApoE-/- groups were fed regular rodent chow throughout the experiments. Mice were housed in a specific pathogen free facility at McGill University, 2-5 animals per cage, and fasted overnight prior to sacrifice by anesthetic overdose (Ketamine/Xylazine/Acepromazine).
###end p 16
###begin p 17
###xml 0 4 0 4 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ApoE</italic>
###xml 4 8 4 8 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 60 64 60 64 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LDLr</italic>
###xml 64 68 64 68 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 106 107 106 107 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T1">1</xref>
###xml 220 224 220 224 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ApoE</italic>
###xml 224 228 224 228 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 279 283 279 283 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LDLr</italic>
###xml 283 287 283 287 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 377 381 377 381 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LDLr</italic>
###xml 381 385 381 385 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 8 12 <span type="species:ncbi:10090">mice</span>
###xml 68 72 <span type="species:ncbi:10090">mice</span>
###xml 287 291 <span type="species:ncbi:10090">mice</span>
###xml 385 389 <span type="species:ncbi:10090">mice</span>
###xml 594 598 <span type="species:ncbi:10090">mice</span>
ApoE-/- mice were sacrificed at 10 and 18 months of age and LDLr-/- mice at 6 and 10 months of age (Table 1). 18 months was judged the greatest age that we could obtain without significant losses due to mortality in the ApoE-/- group. We had originally intended to sacrifice the LDLr-/- mice at 18 months as well, but we found that after 10 months of age on the "Western" diet LDLr-/- mice developed severe health problems. The earlier measurement point for each model is the youngest age where we could reliably obtain measurable atherosclerosis in each case. For both groups, male and female mice were sacrificed at the earlier time-point, and females only at the later time-point.
###end p 17
###begin p 18
Experimental Design
###end p 18
###begin p 19
###xml 128 129 128 129 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T1">1</xref>
###xml 227 231 227 231 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LDLr</italic>
###xml 231 235 231 235 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 345 349 345 349 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LDLr</italic>
###xml 349 353 349 353 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 390 394 390 394 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ApoE</italic>
###xml 394 398 394 398 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 629 633 629 633 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ApoE</italic>
###xml 633 637 633 637 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 905 907 905 907 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B31">31</xref>
###xml 944 950 944 950 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mclk1 </italic>
###xml 1030 1032 1030 1032 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B32">32</xref>
###xml 31 35 <span type="species:ncbi:10090">mice</span>
###xml 132 136 <span type="species:ncbi:10090">Mice</span>
###xml 235 239 <span type="species:ncbi:10090">mice</span>
###xml 274 278 <span type="species:ncbi:10090">mice</span>
###xml 353 357 <span type="species:ncbi:10090">mice</span>
###xml 398 402 <span type="species:ncbi:10090">mice</span>
###xml 637 641 <span type="species:ncbi:10090">mice</span>
The genetic backgrounds of the mice varied somewhat between studies, although they were always consistent within a study (Table 1). Mice on the CBA background were backcrossed 3 times into the C57Bl/6J background to create the LDLr-/- mice sacrificed at 6 months of age and mice on a mixed 129Sv x Balb/c background were backcrossed 6 times for LDLr-/- mice sacrificed at 10 months of age. ApoE-/- mice sacrificed at 10 and 18 months were backcrossed 4 and 3 times respectively out of the CBA background, and those used in the aging experiment were backcrossed 6 times out of a mixed 129Sv x Balb/c background. A second group of ApoE-/- mice sacrificed at 10 months of age was backcrossed 10 times from the same background. In all cases, the C57BL/6J strain made the greatest contribution to the background, which is important because of this strain's relative sensitivity to atherosclerosis development [31], as well as because the ability of Mclk1 heterozygosity to extend lifespan in this strain has been confirmed in our lab [32].
###end p 19
###begin p 20
###xml 29 34 29 34 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mclk1</italic>
###xml 34 38 34 38 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/- </sup>
###xml 50 54 50 54 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ApoE</italic>
###xml 54 58 54 58 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 38 42 <span type="species:ncbi:10090">mice</span>
###xml 70 74 <span type="species:ncbi:10090">mice</span>
To determine the lifespan of Mclk1+/- mice in the ApoE-/- background, mice were kept until either natural death, or evidence of impending mortality (such as sudden drastic weight loss, lack of movement or a severely distended abdomen) necessitating euthanasia.
###end p 20
###begin p 21
All studies were approved by the McGill Faculty of Science Animal Care Committee and conducted according to the guidelines of the Canadian Council on Animal Care.
###end p 21
###begin title 22
Atherosclerosis Severity
###end title 22
###begin p 23
###xml 176 178 176 178 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B33">33</xref>
###xml 179 181 179 181 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B34">34</xref>
The surface area of atherosclerotic lesions was measured on the inner surface of the aorta, from the aortic origin to the iliac branch point, as has been previously described [33,34]. Quantification of staining on the acquired images was carried out using UTHSCSA ImageTool v3.0 (University of Texas Health Science Center in San Antonio, USA), and results were expressed as percentage surface area of the aorta occupied by Oil Red O-staining lesions. The innominate, common carotid and subclavian arteries were excluded from the analysis.
###end p 23
###begin title 24
Plasma Measurements
###end title 24
###begin p 25
###xml 581 583 575 577 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B35">35</xref>
###xml 584 586 578 580 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B37">37</xref>
###xml 877 879 871 873 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B37">37</xref>
###xml 63 67 <span type="species:ncbi:10090">mice</span>
EDTA plasma was collected by cardiac puncture of anaesthetized mice, flash-frozen in liquid nitrogen and stored at -80degreesC. Kits for measuring plasma cholesterol were obtained from Wako Chemicals USA and those for triglycerides from Sigma-Aldrich. Lipid peroxidation, as quantified by the level of malondialdehyde (MDA), was measured with a Thiobarbituric Acid Reactive Substances (TBARS) Assay Kit from ZeptoMetrix Corporation. The TBARS method of measuring MDA has received considerable criticism for being an insufficiently representative measurement of lipid peroxidation [35-37]. Despite this, even some of the harshest critics concede that the assay frequently yields useful results supported by other better-validated assays, although it may be better thought of as a measurement of susceptibility to lipid peroxidation rather than the steady-state level of damage [37].
###end p 25
###begin title 26
Statistics
###end title 26
###begin p 27
The non-parametric Mann-Whitney test was used to compare atherosclerosis surface area in prepared aortas. Otherwise, the unpaired two-tailed Student's t-test was used. Survival curves were compared using the Log-rank (Mantel-Cox) test. Two-way ANOVA with Bonferroni posttests was used for comparing body-weights collected over lifespan. Comparisons were always made between genotypes, within genders, using Prism 4.03 (GraphPad Software, Inc).
###end p 27
###begin title 28
Results
###end title 28
###begin title 29
###xml 0 6 0 6 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mclk1 </italic>
Mclk1 heterozygosity does not decrease the severity of atherosclerosis
###end title 29
###begin p 30
###xml 16 22 16 22 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mclk1 </italic>
###xml 72 77 72 77 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mclk1</italic>
###xml 77 81 77 81 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/- </sup>
###xml 130 134 130 134 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ApoE</italic>
###xml 134 138 134 138 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 142 146 142 146 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LDLr</italic>
###xml 146 150 146 150 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 291 295 291 295 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ApoE</italic>
###xml 295 299 295 299 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 303 307 303 307 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LDLr</italic>
###xml 307 311 307 311 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 354 360 354 360 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mclk1 </italic>
###xml 384 385 384 385 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1</xref>
###xml 390 391 390 391 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2</xref>
###xml 412 416 412 416 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ApoE</italic>
###xml 416 420 416 420 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 458 463 458 463 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mclk1</italic>
###xml 463 467 463 467 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/- </sup>
###xml 640 645 640 645 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mclk1</italic>
###xml 645 649 645 649 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/- </sup>
###xml 884 890 884 890 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mclk1 </italic>
###xml 969 973 969 973 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ApoE</italic>
###xml 973 977 973 977 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 1108 1114 1108 1114 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mclk1 </italic>
###xml 81 85 <span type="species:ncbi:10090">mice</span>
###xml 420 424 <span type="species:ncbi:10090">mice</span>
###xml 713 717 <span type="species:ncbi:10090">mice</span>
###xml 977 981 <span type="species:ncbi:10090">mice</span>
###xml 1079 1083 <span type="species:ncbi:10090">mice</span>
To determine if Mclk1 heterozygosity protected against atherosclerosis, Mclk1+/- mice were crossed into atherosclerosis-sensitive ApoE-/- and LDLr-/- backgrounds. The proportion of the inner aortic surface occupied by atherosclerotic lesions was then quantified. Atherosclerosis in both the ApoE-/- and LDLr-/- models of the disease was not inhibited by Mclk1 heterozygosity (Figures 1 and 2). In one condition (ApoE-/- mice sacrificed at 10 months of age), Mclk1+/- females had increased atherosclerosis (6.8 vs. 10 percent of aortic surface area, p = 0.0146). In the same experiment, there was a 37 percent decrease in atherosclerosis in Mclk1+/- males that was not statistically significant (p = 0.21). As the mice in this cohort had only been backcrossed for four generations, it is possible that high variability due to genetic heterogeneity could have been masking an effect of Mclk1 heterozygosity in males. We therefore repeated this study in a second group of ApoE-/- mice that had been backcrossed ten generations onto the C57BL/6J background. In this second cohort of mice, there was no effect of Mclk1 heterozygosity in either gender.
###end p 30
###begin p 31
###xml 19 25 19 25 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mclk1 </italic>
###xml 65 69 65 69 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LDLr</italic>
###xml 69 73 69 73 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 0 86 0 86 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Heterozygosity for <italic>Mclk1 </italic>does not prevent atherosclerosis in the <italic>LDLr</italic><sup>-/- </sup>disease model</bold>
###xml 215 219 215 219 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LDLr</italic>
###xml 219 223 219 223 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 445 450 445 450 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mclk1</italic>
###xml 450 454 450 454 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+ </sup>
###xml 458 463 458 463 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mclk1</italic>
###xml 463 467 463 467 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/- </sup>
###xml 223 227 <span type="species:ncbi:10090">mice</span>
Heterozygosity for Mclk1 does not prevent atherosclerosis in the LDLr-/- disease model. Atherosclerotic lesions that stain with the lipid-sensitive dye Oil Red O were quantified on the inner surface of the aorta in LDLr-/- mice at (A) 6 months of age, with three backcrosses into C57BL/6J and (B) 10 months of age with six backcrosses into C57BL/6J. F and M labels stand for females and males, respectively. The +/+ and +/- labels stand for the Mclk1+/+ and Mclk1+/- genotypes, respectively.
###end p 31
###begin p 32
###xml 19 25 19 25 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mclk1 </italic>
###xml 65 69 65 69 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ApoE</italic>
###xml 69 73 69 73 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 0 86 0 86 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Heterozygosity for <italic>Mclk1 </italic>does not prevent atherosclerosis in the <italic>ApoE</italic><sup>-/- </sup>disease model</bold>
###xml 215 219 215 219 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ApoE</italic>
###xml 219 223 219 223 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 512 517 512 517 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mclk1</italic>
###xml 517 521 517 521 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+ </sup>
###xml 525 530 525 530 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mclk1</italic>
###xml 530 534 530 534 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/- </sup>
###xml 223 227 <span type="species:ncbi:10090">mice</span>
Heterozygosity for Mclk1 does not prevent atherosclerosis in the ApoE-/- disease model. Atherosclerotic lesions that stain with the lipid-sensitive dye Oil Red O were quantified on the inner surface of the aorta in ApoE-/- mice at (A) 10 months, initial trial with four backcrosses into C57BL/6J, (B) 10 months, second trial with ten backcrosses into C57BL/6J and (C) 18 months, with three backcrosses into C57BL/6J. F and M labels stand for females and males, respectively. The +/+ and +/- labels stand for the Mclk1+/+ and Mclk1+/- genotypes, respectively.
###end p 32
###begin p 33
###xml 13 19 13 19 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mclk1 </italic>
###xml 146 147 146 147 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T2">2</xref>
###xml 204 209 204 209 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mclk1</italic>
###xml 209 212 209 212 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/-</sup>
###xml 214 218 214 218 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ApoE</italic>
###xml 218 222 218 222 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 538 542 538 542 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LDLr</italic>
###xml 542 545 542 545 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 547 552 547 552 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mclk1</italic>
###xml 552 556 552 556 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/- </sup>
###xml 556 560 <span type="species:ncbi:10090">mice</span>
In addition, Mclk1 heterozygosity in these atherosclerosis susceptible backgrounds did not produce any consistent change in lipid profiles (Table 2), including total plasma cholesterol and triglycerides. Mclk1+/-; ApoE-/- males sacrificed at 10 months of age had decreased plasma triglycerides. However, when this experiment was repeated in the fully congenic background, triglycerides were not affected. Instead, we saw an increase in cholesterol levels. Plasma lipid peroxidation was never significantly affected. Body weight of female LDLr-/-; Mclk1+/- mice sacrificed at six months of age was slightly decreased, but we did not see an effect on body weight in any other group.
###end p 33
###begin p 34
Plasma lipid characteristics and body weight at sacrifice (expressed as mean +/- standard deviation)
###end p 34
###begin p 35
*: p < 0.05
###end p 35
###begin title 36
###xml 8 13 8 13 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ApoE </italic>
###xml 60 66 60 66 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mclk1 </italic>
Loss of ApoE suppresses the lifespan extension conferred by Mclk1 heterozygosity
###end title 36
###begin p 37
###xml 16 21 16 21 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mclk1</italic>
###xml 21 25 21 25 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/- </sup>
###xml 36 40 36 40 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ApoE</italic>
###xml 84 89 84 89 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mclk1</italic>
###xml 89 93 89 93 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+ </sup>
###xml 110 111 110 111 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3</xref>
###xml 121 126 121 126 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mclk1</italic>
###xml 126 130 126 130 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/- </sup>
###xml 269 274 269 274 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mclk1</italic>
###xml 274 278 274 278 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/- </sup>
###xml 389 390 389 390 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3</xref>
###xml 643 648 643 648 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mclk1</italic>
###xml 648 652 648 652 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/- </sup>
###xml 807 812 805 810 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mclk1</italic>
###xml 812 816 810 814 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+ </sup>
###xml 843 848 839 844 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mclk1</italic>
###xml 848 851 844 847 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/-</sup>
###xml 976 981 968 973 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mclk1</italic>
###xml 981 984 973 976 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/-</sup>
###xml 1013 1017 1005 1009 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ApoE</italic>
###xml 1017 1021 1009 1013 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 25 29 <span type="species:ncbi:10090">mice</span>
###xml 130 134 <span type="species:ncbi:10090">mice</span>
###xml 278 282 <span type="species:ncbi:10090">mice</span>
###xml 633 637 <span type="species:ncbi:10090">mice</span>
###xml 1021 1025 <span type="species:ncbi:10090">mice</span>
###xml 1064 1068 <span type="species:ncbi:10090">mice</span>
###xml 1167 1171 <span type="species:ncbi:10090">mice</span>
Male and female Mclk1+/- mice on an ApoE-null background failed to live longer than Mclk1+/+ controls (Figure 3). Female Mclk1+/- mice actually had a shorter average lifespan than controls, although this difference did not reach statistical significance (p = 0.16). In Mclk1+/- mice of both genders, body weight was decreased throughout life (p < 0.0001 females, p = 0.0064 males) (Figure 3). 21 out of 35 females and 9 out of 18 males were euthanized as they were obviously near death due to severe illness (proportions were equal for each genotype), with the remainder dying naturally. Atherosclerosis was quantified in euthanized mice, and Mclk1+/- females appeared to have decreased atherosclerosis relative to controls, although this difference did not reach statistical significance (16.4 +/- 12.5 in Mclk1+/+ vs. 9.6 +/- 5.8 percent in Mclk1+/-, p = 0.18 by Mann-Whitney test). Atherosclerosis was not affected in males (20.3 +/- 14.25 in wild-type vs. 23 +/- 16.57 in Mclk1+/-, p = 0.63). In the group of ApoE-/- mice sacrificed at 18 months of age, three mice of each genotype died prior to their date of sacrifice, closely paralleling the survival curve of mice in the lifespan study.
###end p 37
###begin p 38
###xml 56 61 56 61 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mclk1</italic>
###xml 61 65 61 65 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+ </sup>
###xml 68 72 68 72 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/- </sup>
###xml 84 88 84 88 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ApoE</italic>
###xml 88 92 88 92 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 0 102 0 102 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Survival curves and body weights throughout lifespan of <italic>Mclk1</italic><sup>+/+ </sup>and<sup>+/- </sup>mice on the <italic>ApoE</italic><sup>-/- </sup>background</bold>
###xml 161 167 161 167 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mclk1 </italic>
###xml 490 495 490 495 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mclk1</italic>
###xml 495 499 495 499 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+ </sup>
###xml 503 508 503 508 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mclk1</italic>
###xml 508 512 508 512 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/- </sup>
###xml 72 76 <span type="species:ncbi:10090">mice</span>
###xml 183 187 <span type="species:ncbi:10090">Mice</span>
Survival curves and body weights throughout lifespan of Mclk1+/+ and+/- mice on the ApoE-/- background. Survival of (A) female and (B) males was not affected by Mclk1 heterozygosity. Mice were weighed weekly, and the monthly average was plotted with the standard error of the mean for (C) females and (D) males. For both (C) and (D) the difference between genotypes was significant at p < 0.01. F and M labels stand for females and males, respectively. The +/+ and +/- labels stand for the Mclk1+/+ and Mclk1+/- genotypes, respectively.
###end p 38
###begin title 39
Discussion
###end title 39
###begin title 40
###xml 14 20 14 20 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mclk1 </italic>
The effect of Mclk1 heterozygosity on atherosclerosis
###end title 40
###begin p 41
###xml 41 47 41 47 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mclk1 </italic>
###xml 127 132 127 132 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mclk1</italic>
###xml 132 136 132 136 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/- </sup>
###xml 465 471 465 471 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mclk1 </italic>
###xml 823 829 823 829 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mclk1 </italic>
###xml 100 104 <span type="species:ncbi:10090">mice</span>
###xml 136 140 <span type="species:ncbi:10090">mice</span>
###xml 342 346 <span type="species:ncbi:10090">mice</span>
In five separate studies, we showed that Mclk1 heterozygosity did not ameliorate atherosclerosis in mice. In one study, female Mclk1+/- mice showed a statistically significant increase in atherosclerosis, and males showed a non-significant decrease. However, we were unable to repeat either of these results in a follow-up study in which the mice were in a fully congenic background. Our experiments covered a range of ages and severity of disease, indicating that Mclk1 heterozygosity did not have any beneficial age-dependent or -independent effects on atherosclerosis. In other words, we only observed an effect on atherosclerosis in one particular genetic background, suggesting that it was due to a unique set of interactions within this particular background. This forces us to conclude that any potential effects of Mclk1 heterozygosity on atherosclerosis would not be due to the same mechanism as that which produces lifespan extension, which was observed in several separate backgrounds.
###end p 41
###begin p 42
###xml 37 42 37 42 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mclk1</italic>
###xml 42 46 42 46 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/- </sup>
###xml 311 312 311 312 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B9">9</xref>
###xml 401 406 401 406 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mclk1</italic>
###xml 406 410 406 410 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/- </sup>
###xml 478 480 478 480 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B38">38</xref>
###xml 614 619 614 619 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mclk1</italic>
###xml 619 623 619 623 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/- </sup>
###xml 850 854 850 854 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ApoE</italic>
###xml 854 858 854 858 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 902 907 902 907 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mclk1</italic>
###xml 907 911 907 911 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/- </sup>
###xml 1058 1060 1058 1060 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B39">39</xref>
###xml 1102 1107 1102 1107 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mclk1</italic>
###xml 1107 1111 1107 1111 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/- </sup>
###xml 46 50 <span type="species:ncbi:10090">mice</span>
###xml 142 146 <span type="species:ncbi:10090">mice</span>
###xml 410 414 <span type="species:ncbi:10090">mice</span>
###xml 623 627 <span type="species:ncbi:10090">mice</span>
###xml 858 862 <span type="species:ncbi:10090">mice</span>
###xml 911 915 <span type="species:ncbi:10090">mice</span>
###xml 1111 1115 <span type="species:ncbi:10090">mice</span>
We have recently reported that young Mclk1+/- mice have decreased lipid peroxidation, measured via plasma isoprostanes. At the same time, the mice had substantial alterations in mitochondrial function, including a general decrease in mitochondrial respiration and an increase in mitochondrial oxidative stress [9]. Mitochondrial dysfunction linked to increased oxidative stress, such as that found in Mclk1+/- mice, has been shown to increase susceptibility to atherosclerosis [38]. The balance between mitochondrial, atherosclerosis-sensitizing and systemic, potentially atherosclerosis-protective, phenotypes of Mclk1+/- mice may explain the general absence of a significant effect on atherosclerosis that we observed. This balance may be modulated by genetic background, which could account for some of the contrasting results we observed between ApoE-/- mice of different backgrounds. Furthermore, Mclk1+/- mice also have higher levels of several pro-inflammatory cytokines (unpublished data). Inflammation plays a role in all stages of atherosclerosis [39], suggesting another possible reason why Mclk1+/- mice are not protected against the disease.
###end p 42
###begin title 43
###xml 21 27 21 27 <italic xmlns:xlink="http://www.w3.org/1999/xlink">clk-1 </italic>
###xml 30 41 30 41 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. elegans </italic>
###xml 45 51 45 51 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mclk1 </italic>
###xml 30 40 <span type="species:ncbi:6239">C. elegans</span>
###xml 54 58 <span type="species:ncbi:10090">mice</span>
The effect of mutant clk-1 in C. elegans and Mclk1 in mice on lipid metabolism
###end title 43
###begin p 44
###xml 0 6 0 6 <italic xmlns:xlink="http://www.w3.org/1999/xlink">clk-1 </italic>
###xml 64 66 64 66 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
###xml 67 69 67 69 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
###xml 336 341 336 341 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mclk1</italic>
###xml 341 345 341 345 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/- </sup>
###xml 355 361 355 361 <italic xmlns:xlink="http://www.w3.org/1999/xlink">clk-1 </italic>
###xml 483 484 483 484 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B2">2</xref>
###xml 485 487 485 487 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B40">40</xref>
###xml 633 634 633 634 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B3">3</xref>
###xml 635 636 635 636 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 637 638 637 638 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B9">9</xref>
###xml 682 687 682 687 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MCLK1</italic>
###xml 688 694 688 694 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CLK-1 </italic>
###xml 834 840 834 840 <italic xmlns:xlink="http://www.w3.org/1999/xlink">clk-1 </italic>
###xml 933 935 933 935 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B41">41</xref>
###xml 936 938 936 938 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B42">42</xref>
###xml 941 946 941 946 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mclk1</italic>
###xml 946 950 946 950 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/- </sup>
###xml 1043 1044 1043 1044 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B3">3</xref>
###xml 1045 1046 1045 1046 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B9">9</xref>
###xml 1201 1206 1201 1206 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mclk1</italic>
###xml 1206 1210 1206 1210 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/- </sup>
###xml 1292 1303 1292 1303 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. elegans </italic>
###xml 117 121 <span type="species:ncbi:10090">mice</span>
###xml 232 236 <span type="species:ncbi:10090">mice</span>
###xml 345 349 <span type="species:ncbi:10090">mice</span>
###xml 509 513 <span type="species:ncbi:10090">mice</span>
###xml 676 680 <span type="species:ncbi:10090">mice</span>
###xml 950 954 <span type="species:ncbi:10090">mice</span>
###xml 1090 1094 <span type="species:ncbi:10090">mice</span>
###xml 1210 1215 <span type="species:ncbi:10090">mouse</span>
###xml 1292 1302 <span type="species:ncbi:6239">C. elegans</span>
clk-1 mutant worms have altered oxidative and lipid metabolism [16,19]. The organismal differences between worms and mice, as well as other differences between the two models (homozygous mutants in worms and heterozygous mutants in mice) may explain why we did not the see the expected effect on lipid metabolism and atherosclerosis in Mclk1+/- mice. The clk-1 mutant worms are homozygous for alleles incapable of producing UQ, resulting in an obvious, easily observable, phenotype [2,40]. On the other hand, mice retain one copy of the wild-type allele, and the MCLK1 produced appears sufficient for a normal level of UQ synthesis [3,7,9]. It appears that, in both worms and mice, MCLK1/CLK-1 has an additional function besides the production of UQ. This is supported by evidence from both organisms. In worms, two mutant alleles of clk-1 yield phenotypes of different severity, despite the fact that neither allele can produce UQ [41,42]. Mclk1+/- mice actually have several very clear biochemical phenotypes despite wild-type levels of UQ [3,9]. Yet, the absence of a lipid phenotype in mice suggests the existence of a threshold that is not reached when CLK-1/MCLK1 activity is only reduced as in Mclk1+/- mouse mutants rather than completely abolished or very severely reduced as in the C. elegans mutants.
###end p 44
###begin title 45
###xml 15 20 15 20 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mclk1</italic>
###xml 20 24 20 24 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/- </sup>
###xml 45 49 45 49 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ApoE</italic>
Suppression of Mclk1+/- longevity by loss of ApoE
###end title 45
###begin p 46
###xml 34 40 34 40 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mclk1 </italic>
###xml 126 130 126 130 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ApoE</italic>
###xml 130 134 130 134 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 179 184 179 184 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mclk1</italic>
###xml 184 188 184 188 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/- </sup>
###xml 205 210 205 210 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mclk1</italic>
###xml 210 214 210 214 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+ </sup>
###xml 242 247 242 247 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mclk1</italic>
###xml 247 250 247 250 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/-</sup>
###xml 252 256 252 256 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ApoE</italic>
###xml 256 260 256 260 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 292 297 292 297 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mclk1</italic>
###xml 297 300 297 300 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+</sup>
###xml 302 306 302 306 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ApoE</italic>
###xml 306 310 306 310 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 386 391 386 391 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mclk1</italic>
###xml 391 395 391 395 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/- </sup>
###xml 414 418 414 418 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ApoE</italic>
###xml 503 504 503 504 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
###xml 544 549 544 549 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ApoE </italic>
###xml 576 581 576 581 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mclk1</italic>
###xml 581 585 581 585 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/- </sup>
###xml 727 732 727 732 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mclk1</italic>
###xml 732 736 732 736 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/- </sup>
###xml 817 822 817 822 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mclk1</italic>
###xml 822 826 822 826 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/- </sup>
###xml 1057 1061 1057 1061 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ApoE</italic>
###xml 1061 1065 1061 1065 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 1156 1158 1156 1158 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B43">43</xref>
###xml 1176 1180 1176 1180 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ApoE</italic>
###xml 1180 1184 1180 1184 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 1372 1374 1372 1374 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B24">24</xref>
###xml 1375 1377 1375 1377 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B44">44</xref>
###xml 1408 1412 1408 1412 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ApoE</italic>
###xml 1412 1416 1412 1416 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 1487 1489 1487 1489 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B45">45</xref>
###xml 1509 1511 1509 1511 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B46">46</xref>
###xml 1540 1545 1540 1545 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mclk1</italic>
###xml 1545 1549 1545 1549 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/- </sup>
###xml 1794 1799 1794 1799 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mclk1</italic>
###xml 1799 1803 1799 1803 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/- </sup>
###xml 1929 1933 1929 1933 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ApoE</italic>
###xml 1933 1937 1933 1937 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 3 7 <span type="species:ncbi:10090">mice</span>
###xml 188 192 <span type="species:ncbi:10090">mice</span>
###xml 214 218 <span type="species:ncbi:10090">mice</span>
###xml 260 264 <span type="species:ncbi:10090">mice</span>
###xml 310 314 <span type="species:ncbi:10090">mice</span>
###xml 395 399 <span type="species:ncbi:10090">mice</span>
###xml 585 589 <span type="species:ncbi:10090">mice</span>
###xml 736 740 <span type="species:ncbi:10090">mice</span>
###xml 833 837 <span type="species:ncbi:10090">mice</span>
###xml 1065 1069 <span type="species:ncbi:10090">mice</span>
###xml 1148 1154 <span type="species:ncbi:9606">humans</span>
###xml 1184 1188 <span type="species:ncbi:10090">mice</span>
###xml 1416 1420 <span type="species:ncbi:10090">mice</span>
###xml 1549 1553 <span type="species:ncbi:10090">mice</span>
###xml 1803 1807 <span type="species:ncbi:10090">mice</span>
###xml 1937 1941 <span type="species:ncbi:10090">mice</span>
In mice lacking the ApoE protein, Mclk1 heterozygosity no longer extends lifespan. In other words, some characteristic of the ApoE-/- background actually shortens the lifespan of Mclk1+/- mice relative to Mclk1+/+ mice. We also observed that Mclk1+/-; ApoE-/- mice weighed slightly less than Mclk1+/+; ApoE-/- mice, starting at approximately 1 year of age. This is in contrast to older Mclk1+/- mice wild-type for ApoE, which either weigh the same or more than wild-type controls [unpublished data and [1]]. This does imply that the absence of ApoE has detrimental effects on Mclk1+/- mice. An increased prevalence of atherosclerosis is unlikely to be the cause of this lifespan shortening effect. Firstly, as described above, Mclk1+/- mice do not appear more susceptible to atherosclerosis development. If anything, Mclk1+/- female mice in the aging experiment that were euthanized due to impending death showed a trend of slightly less aortic atherosclerosis than their wild-type controls. Secondly, it has been surprisingly difficult to find evidence in ApoE-/- mice of the arterial occlusion-induced cardiovascular events that are so lethal to humans [43]. Although older ApoE-/- mice may develop atherosclerosis of the coronary arteries, only a small proportion of these are found to display evidence of more advanced coronary artery disease, such as plaque rupture [24,44]. Aside from atherosclerosis, ApoE-/- mice suffer from other conditions, such as increased oxidative stress [45] and inflammation [46]. As described above, young Mclk1+/- mice have higher levels of oxidative stress in mitochondria as well as greater expression of certain cytokines consistent with a more pro-inflammatory state. Although these factors by themselves clearly do not prevent the increased longevity of Mclk1+/- mice, they may exert a negative effect that cancels out the lifespan extension when combined with corresponding phenotypes in ApoE-/- mice.
###end p 46
###begin title 47
Conclusion
###end title 47
###begin p 48
###xml 65 70 65 70 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mclk1</italic>
###xml 70 74 70 74 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/- </sup>
###xml 80 86 80 86 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mclk1 </italic>
###xml 246 252 246 252 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mclk1 </italic>
###xml 417 423 417 423 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mclk1 </italic>
###xml 470 474 470 474 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ApoE</italic>
###xml 508 514 508 514 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mclk1 </italic>
###xml 627 631 627 631 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ApoE</italic>
###xml 74 78 <span type="species:ncbi:10090">mice</span>
###xml 637 641 <span type="species:ncbi:10090">mice</span>
Contrary to our expectations based on the increased longevity of Mclk1+/- mice, Mclk1 heterozygosity does not protect against atherosclerosis. This is not surprising in light of recent findings that suggest a complex pattern of phenotypes due to Mclk1 heterozygosity, some of which may actually facilitate development of a disease such as atherosclerosis that involves oxidative stress and inflammation. Furthermore, Mclk1 heterozygosity does not extend lifespan in the ApoE-null background, suggesting that Mclk1 heterozygosity is not capable of protecting against the increased oxidative stress and inflammation that afflict ApoE-null mice.
###end p 48
###begin title 49
Competing interests
###end title 49
###begin p 50
The authors declare that they have no competing interests.
###end p 50
###begin title 51
Authors' contributions
###end title 51
###begin p 52
BH participated in the conception and design of this study, performed the experiments, participated in the analysis of data, and helped write the paper. SH participated in the conception and design of the study, participated in the analysis of data, and helped write the paper.
###end p 52
###begin title 53
Authors' Information
###end title 53
###begin p 54
SH is Campbell Chair of Developmental Biology and Strathcona Chair of Zoology.
###end p 54
###begin title 55
Acknowledgements
###end title 55
###begin p 56
We thank Eve Bigras for expert technical assistance. This study was funded by McGill University.
###end p 56
###begin article-title 57
###xml 130 134 <span type="species:ncbi:10090">mice</span>
Evolutionary conservation of the clk-1-dependent mechanism of longevity: loss of mclk1 increases cellular fitness and lifespan in mice
###end article-title 57
###begin article-title 58
###xml 31 53 <span type="species:ncbi:6239">Caenorhabditis elegans</span>
Mutations in the clk-1 gene of Caenorhabditis elegans affect developmental and behavioral timing
###end article-title 58
###begin article-title 59
###xml 118 122 <span type="species:ncbi:10090">mice</span>
Reversal of the mitochondrial phenotype and slow development of oxidative biomarkers of aging in long-lived Mclk1 +/- mice
###end article-title 59
###begin article-title 60
###xml 46 68 <span type="species:ncbi:6239">Caenorhabditis elegans</span>
Structural and functional conservation of the Caenorhabditis elegans timing gene clk-1
###end article-title 60
###begin article-title 61
A new member of the family of di-iron carboxylate proteins. Coq7 (clk-1), a membrane-bound hydroxylase involved in ubiquinone biosynthesis
###end article-title 61
###begin article-title 62
Metabolism and function of coenzyme Q
###end article-title 62
###begin article-title 63
###xml 28 33 <span type="species:ncbi:10090">mouse</span>
Ubiquinone is necessary for mouse embryonic development but is not essential for mitochondrial respiration
###end article-title 63
###begin article-title 64
###xml 0 5 <span type="species:ncbi:10090">Mouse</span>
###xml 49 71 <span type="species:ncbi:6239">Caenorhabditis elegans</span>
Mouse homologue of coq7/clk-1, longevity gene in Caenorhabditis elegans, is essential for coenzyme Q synthesis, maintenance of mitochondrial integrity, and neurogenesis
###end article-title 64
###begin article-title 65
###xml 56 60 <span type="species:ncbi:10090">Mice</span>
Early Mitochondrial Dysfunction in Long-lived Mclk1 +/- Mice
###end article-title 65
###begin article-title 66
Morbidity profiles of centenarians: survivors, delayers, and escapers
###end article-title 66
###begin article-title 67
Cancer in the oldest old
###end article-title 67
###begin article-title 68
Atherosclerosis. The Road Ahead
###end article-title 68
###begin article-title 69
###xml 108 112 <span type="species:ncbi:10090">mice</span>
Dietary restriction reduces atherosclerosis and oxidative stress in the aorta of apolipoprotein E-deficient mice
###end article-title 69
###begin article-title 70
###xml 136 140 <span type="species:ncbi:10090">mice</span>
Deletion of the p66Shc longevity gene reduces systemic and tissue oxidative stress, vascular cell apoptosis, and early atherogenesis in mice fed a high-fat diet
###end article-title 70
###begin article-title 71
Respiratory uncoupling in skeletal muscle delays death and diminishes age-related disease
###end article-title 71
###begin article-title 72
###xml 55 77 <span type="species:ncbi:6239">Caenorhabditis elegans</span>
Redox regulation of germline and vulval development in Caenorhabditis elegans
###end article-title 72
###begin article-title 73
###xml 45 67 <span type="species:ncbi:6239">Caenorhabditis elegans</span>
Distribution and Transport of Cholesterol in Caenorhabditis elegans
###end article-title 73
###begin article-title 74
Molecular diversity and evolution of the large lipid transfer protein superfamily
###end article-title 74
###begin article-title 75
Evolutionary conservation of drug action on lipoprotein metabolism-related targets
###end article-title 75
###begin article-title 76
The role of oxidative damage and stress in aging
###end article-title 76
###begin article-title 77
Molecular inflammation: Underpinnings of aging and age-related diseases
###end article-title 77
###begin article-title 78
###xml 0 5 <span type="species:ncbi:10090">Mouse</span>
Mouse Models for Atherosclerosis and Pharmaceutical Modifiers
###end article-title 78
###begin article-title 79
###xml 58 63 <span type="species:ncbi:10090">mouse</span>
Cellular and molecular mechanisms of atherosclerosis with mouse models
###end article-title 79
###begin article-title 80
###xml 15 19 <span type="species:ncbi:10090">mice</span>
ApoE-deficient mice develop lesions of all phases of atherosclerosis throughout the arterial tree
###end article-title 80
###begin article-title 81
Prevalence and extent of atherosclerosis in adolescents and young adults: implications for prevention from the Pathobiological Determinants of Atherosclerosis in Youth Study
###end article-title 81
###begin article-title 82
###xml 104 108 <span type="species:ncbi:10090">mice</span>
Loss of functional farnesoid x receptor increases atherosclerotic lesions in apolipoprotein E-deficient mice
###end article-title 82
###begin article-title 83
###xml 58 62 <span type="species:ncbi:10090">mice</span>
FXR deficiency causes reduced atherosclerosis in Ldlr -/- mice
###end article-title 83
###begin article-title 84
###xml 207 211 <span type="species:ncbi:10090">mice</span>
Compared with saturated fatty acids, dietary monounsaturated fatty acids and carbohydrates increase atherosclerosis and VLDL cholesterol levels in LDL receptor-deficient, but not apolipoprotein E-deficient, mice
###end article-title 84
###begin article-title 85
###xml 66 70 <span type="species:ncbi:10090">mice</span>
Hypercholesterolemia in low density lipoprotein receptor knockout mice and its reversal by adenovirus-mediated gene delivery
###end article-title 85
###begin article-title 86
###xml 14 18 <span type="species:ncbi:10090">mice</span>
Generation of mice carrying a mutant apolipoprotein E gene inactivated by gene targeting in embryonic stem cells
###end article-title 86
###begin article-title 87
###xml 94 98 <span type="species:ncbi:10090">mice</span>
Atherosclerosis susceptibility differences among progenitors of recombinant inbred strains of mice
###end article-title 87
###begin article-title 88
The age of heterozygosity
###end article-title 88
###begin article-title 89
###xml 37 41 <span type="species:ncbi:10090">Mice</span>
Quantification of Atherosclerosis in Mice
###end article-title 89
###begin article-title 90
###xml 102 106 <span type="species:ncbi:10090">mice</span>
Rapid regression of atherosclerosis induced by liver-directed gene transfer of ApoE in ApoE-deficient mice
###end article-title 90
###begin article-title 91
Malondialdehyde and thiobarbituric acid-reactivity as diagnostic indices of lipid peroxidation and peroxidative tissue injury
###end article-title 91
###begin article-title 92
Biomarkers of oxidative stress study II: are oxidation products of lipids, proteins, and DNA markers of CCl4 poisoning?
###end article-title 92
###begin article-title 93
A review of recent studies on malondialdehyde as toxic molecule and biological marker of oxidative stress
###end article-title 93
###begin article-title 94
Mitochondrial Integrity and Function in Atherogenesis
###end article-title 94
###begin article-title 95
Inflammation and cardiovascular disease mechanisms
###end article-title 95
###begin article-title 96
###xml 64 86 <span type="species:ncbi:6239">Caenorhabditis elegans</span>
Altered quinone biosynthesis in the long-lived clk-1 mutants of Caenorhabditis elegans
###end article-title 96
###begin article-title 97
###xml 69 91 <span type="species:ncbi:6239">Caenorhabditis elegans</span>
A dietary source of coenzyme Q is essential for growth of long-lived Caenorhabditis elegans clk-1 mutants
###end article-title 97
###begin article-title 98
###xml 15 37 <span type="species:ncbi:6239">Caenorhabditis elegans</span>
Sensitivity of Caenorhabditis elegans clk-1 mutants to ubiquinone side-chain length reveals multiple ubiquinone-dependent processes
###end article-title 98
###begin article-title 99
Rupture of the atherosclerotic plaque: does a good animal model exist?
###end article-title 99
###begin article-title 100
###xml 109 113 <span type="species:ncbi:10090">mice</span>
Spontaneous plaque rupture and secondary thrombosis in apolipoprotein E-deficient and LDL receptor-deficient mice
###end article-title 100
###begin article-title 101
###xml 69 73 <span type="species:ncbi:10090">mice</span>
Oxidatively damaged DNA in aging dyslipidemic ApoE -/- and wild-type mice
###end article-title 101
###begin article-title 102
Dyslipidemia associated with atherosclerotic disease systemically alters dendritic cell mobilization
###end article-title 102

